MiR-155 controls follicular Treg cell-mediated humoral autoimmune intestinal injury by inhibiting CTLA-4 expression
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 71, 267-276
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shaanxi Province (2017JM8139)
- National Natural Science Foundation of China (81800082)
This publication has 30 references indexed in Scilit:
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and CancerImmunity, 2013
- Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulationTrends in Immunology, 2011
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell DevelopmentImmunity, 2010
- MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte–associated antigen 4Journal of Allergy and Clinical Immunology, 2010
- CTLA-4 Control over Foxp3 + Regulatory T Cell FunctionScience, 2008
- microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma CellsImmunity, 2007
- Regulation of the Germinal Center Response by MicroRNA-155Science, 2007
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in miceGut, 2005
- Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3Immunity, 2005